List view / Grid view

Anker Lundemose

 

news

MISSION Therapeutics receives funding for DUB cancer programme

Deubiquitylating enzymes (DUBs) are involved in multiple cellular processes, including…

24 September 2015 | By Victoria White

Deubiquitylating enzymes (DUBs) are involved in multiple cellular processes, including DNA damage and cell proliferation, and the inhibition of these enzymes has considerable potential for the generation of novel drugs...